A clinical trial to Study the effects of two different doses of a drug clonidine with ropivacaine in patients undergoing below umbilicus surgeries
Not Applicable
- Conditions
- Health Condition 1: 4- Measurement and Monitoring
- Registration Number
- CTRI/2023/11/060067
- Lead Sponsor
- Dr Umesh N P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients aged between 18 to 60 years posted for elective infraumbilical surgeries
ASA physical status grade I and II
Patients willing to give informed consent to participate in the study
Exclusion Criteria
Patients who are morbidly obese BMI more than 40kg/m2
Patients allergic to study anesthetic drugs
Patients shorter than 150cm and taller than 180cm height
Patients posted foe emergency surgeries
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the sensory and motor characterstics of clonidine in two different doses when added to intrathecal hyperbaric ropivacaine 0.75% in infraumbilical surgeries. <br/ ><br>To compare the duration of analgesia of clonidine in two different doses in study subjects.Timepoint: To compare the sensory and motor characterstics of clonidine in two different doses when added to intrathecal hyperbaric ropivacaine 0.75% in infraumbilical surgeries at baseline. <br/ ><br>To compare the duration of analgesia of clonidine in two different doses in study subjects upto 8hrs
- Secondary Outcome Measures
Name Time Method To compare the level of sedation, perioperative hemodynamic changes, side effects such as nausea, vomiting, shivering, pruritis, respiratory depression etc in the study subjects.Timepoint: 24 hours